FMC CorporationShares surged 15.8% despite revenue miss and guidance cut, driven by debt reduction progress including Tessenderlo investment, Corteva payment, and India business sale.
FMC Corporation shares rallied 15.8% on Thursday after the agricultural chemicals company reported second-quarter earnings that missed revenue expectations and lowered full-year guidance. Revenue fell 17% to $867 million, missing estimates by $30 million, while adjusted earnings per share of $0.26 beat expectations despite a 62% decline from the prior year. Management now forecasts full-year revenue of $3.5 billion to $3.7 billion, down from a prior range of $3.6 billion to $3.8 billion, and adjusted EPS of $1.34 at the midpoint, down from $1.76. The stock's surge came off a deeply depressed valuation, as investors appeared to welcome progress on debt reduction, including a $400 million investment from Tessenderlo Group for a 20% stake, a $200 million upfront payment from Corteva for rimisoxafen technology, and the $252 million sale of its India business to Crystal Crop Protection Limited. These moves support management's goal of paying down $1 billion in debt this year, offering a measure of relief for a company whose shares had fallen over 90% since early 2023.
FMC CorporationShares surged 15.8% despite revenue miss and guidance cut, driven by debt reduction progress including Tessenderlo investment, Corteva payment, and India business sale.
Tessenderlo Group N.V.Tessenderlo Group invested $400 million for a 20% stake in FMC, a positive capital move for Tessenderlo (acquiring stake).
Corteva IncCorteva made a $200 million upfront payment to FMC for rimisoxafen technology, which is a positive capital event for Corteva (acquiring technology).
Crystal Crop Protection Limited acquired FMC's India business for $252 million, a positive capital event for Crystal (acquiring business).